Design
Review
Authors
Loading...
May support antioxidant strategies to mitigate chemotherapy cardiotoxicity; leaves open prospective trials before clinical adoption.
Oxidative stress is a key mechanism underlying the toxicity of chemotherapeutic agents like doxorubicin in non-targeted tissues such as the heart, highlighting a potential target for cardioprotective strategies.
Chen et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: